Skip to main content
Log in

Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease

  • Published:
Lung Aims and scope Submit manuscript

Abstract

Pulmonary hypertension (PH) is associated with decreased overall survival in patients with chronic lung disease. The purpose of this study was to determine the effect of echocardiographic evidence of PH on 1-year survival in patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease (COPD). This is a retrospective study of patients admitted to a respiratory intermediate care unit with COPD exacerbation between October 1, 2002 and September 30, 2004. All patients who had 2D echocardiograms and pulmonary function tests done within 12 months prior to hospital admission or during the admission were examined. Charts were reviewed for the following outcomes: length of hospital stay, need for mechanical ventilation, survival at discharge, and mortality over the next year. Data were analyzed using multiple logistic regression and p values calculated using Fisher’s exact test. Forty-three patients met study entry criteria, and PH, defined as systolic right ventricular pressure greater than 45 mmHg, was found in 23 (53%). Sixteen of the 23 patients (70%) with PH died during the 1-year follow-up period compared to 5 of 20 (25%) patients with no PH (p = 0.0058). The effect of PH on survival was independent of age, forced expiratory volume in 1 s (FEV1), arterial pH, pCO2, or pO2 (p < 0.01). Echocardiographic evidence of PH is associated with increased 1-year mortality in patients admitted with COPD exacerbation. Further studies are needed to determine if PH is a cause of increased mortality in this population or an indicator of other cardiovascular disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

BMI:

Body mass index

COPD:

Chronic obstructive pulmonary disease

FEV1 :

Forced expiratory volume in one second

GOLD:

Global Initiative for Chronic Obstructive Lung Disease

ICD9:

International Classification of Diseases

mmHg:

Millimeters of mercury

PAP:

Pulmonary arterial pressure

mPAP:

Mean pulmonary arterial pressure

PAH:

Pulmonary arterial hypertension

pCO2 :

Partial pressure of carbon dioxide

PFT:

Pulmonary function test

PH:

Pulmonary hypertension

pO2 :

Partial pressure of oxygen

RAP:

Right atrial pressure

RV:

Right ventricle

RVSP:

Right ventricular systolic pressure

sPAP:

Systolic pulmonary artery pressure

TR:

Tricuspid regurgitation

TRV:

Tricuspid regurgitant velocity

References

  1. Mannino DM, Gagnon RC, Petty TL et al (2000) Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 160:1683–1689

    Article  PubMed  CAS  Google Scholar 

  2. Mannino DM, Homa DM, Akinbami LJ et al (2002) Surveillance for asthma–United States, 1980–1999. MMWR Surveill Summ 51:1–13

    Google Scholar 

  3. Ourednik A, Suza Z (1975) How long does the pulmonary hypertension last in chronic obstructive pulmonary disease? In: Widimsky J (ed) Progress in respiratory research: pulmonary hypertension. Karger, Basel, pp 4–28

    Google Scholar 

  4. Weitzenblum E, Hirth C, Ducolone A et al (1981) Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax 36:752–758

    Article  PubMed  CAS  Google Scholar 

  5. Cooper R, Ghali J, Simmons BE et al (1991) Elevated pulmonary artery pressure. An independent predictor of mortality. Chest 99:112–120

    Article  PubMed  CAS  Google Scholar 

  6. Kessler R, Faller M, Fourgaut G et al (1999) Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159:158–164

    PubMed  CAS  Google Scholar 

  7. Oswald-Mammosser M, Weitzenblum E, Quoix E et al (1995) Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest 107:1193–1198

    Article  PubMed  CAS  Google Scholar 

  8. Smith KJ, Pesce RR (1994) Pulmonary artery catheterization in exacerbations of COPD requiring mechanical ventilation: a cost-effectiveness analysis. Respir Care 39(10):961–967

    PubMed  CAS  Google Scholar 

  9. Higham MA, Dawson D, Joshi J et al (2001) Utility of echocardiography in assessment of pulmonary hypertension secondary to COPD. Eur Respir J 17(3):350–355

    Article  PubMed  CAS  Google Scholar 

  10. Chaouat A, Bugnet AS, Kadaoui N et al (2005) Severe pulmonary hypertension and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 172(2):189–194

    Article  PubMed  Google Scholar 

  11. Weitzenblum E, Chaouat A (2005) Severe pulmonary hypertension in COPD: is it a distinct disease? Chest 127(5):1480–1482

    Article  PubMed  Google Scholar 

  12. Wuertemberger G, Zielinsky J, Sliwinsky P (1990) Survival in chronic obstructive pulmonary disease after diagnosis of pulmonary hypertension related to long-term oxygen therapy. Lung Suppl 168:762–769

    Article  Google Scholar 

  13. Arcasoy SM, Christie JD, Ferrari VA et al (2003) Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med 167:735–740

    Article  PubMed  Google Scholar 

  14. Bredikis AJ, Liebson PR (1998) The echocardiogram in COPD: estimating right heart pressures. J Respir Dis 19:191–198

    Google Scholar 

  15. Fabbri LM, Hurd SS (2003) GOLD scientific committee. Global strategy for the diagnosis, management and prevention of COPD: 2003 update. Eur Respir J 22(1):1–2

    Article  PubMed  CAS  Google Scholar 

  16. Simonson JS, Schiller NB (1988) Sonospirometry: a new method for noninvasive estimation of mean right atrial pressure based on two-dimensional echographic measurements of the inferior vena cava during measured inspiration. J Am Coll Cardiol 11:557–564

    Article  PubMed  CAS  Google Scholar 

  17. Groenewegen KH, Schols AM, Wouters EF (2003) Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 124(2):459–467

    Article  PubMed  Google Scholar 

  18. Sukumalchantra Y, Dinakara P, Williams MH (1966) Prognosis of patients with chronic obstructive pulmonary disease after hospitalization for acute ventilatory failure: a three year follow-up study. Am Rev Respir Dis 93:215–222

    PubMed  CAS  Google Scholar 

  19. Blanco I, Gimeno E, Munoz PA et al (2010) Hemodynamic and gas exchange effects of sildenafil in patients with chronic obstructive pulmonary disease and pulmonary hypertension. Am J Respir Crit Care Med 181:270–278

    Article  PubMed  CAS  Google Scholar 

  20. Stolz D, Rasch H, Linka A et al (2008) A randomised, controlled trial of bosentan in severe COPD. Eur Respir J 32:619–628

    Article  PubMed  CAS  Google Scholar 

  21. Thabut G, Dauriat G, Stern JB et al (2005) Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest 127:1531–1536

    Article  PubMed  Google Scholar 

  22. Scharf SM, Iqbal M, Keller C, National Emphysema Treatment Trial (NETT) Group et al (2002) Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med 166:314–322

    Article  PubMed  Google Scholar 

  23. Joppa P, Petrasova D, Stancak B et al (2006) Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 130:326–333

    Article  PubMed  CAS  Google Scholar 

  24. Fisher MR, Forfia PR, Chamera E et al (2009) Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension. Am J Respir Crit Care Med 179:615–621

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This study was supported by AHA Established Investigator Grant HN 240914 (JRK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James R. Klinger.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Stone, A.C., Machan, J.T., Mazer, J. et al. Echocardiographic Evidence of Pulmonary Hypertension is Associated with Increased 1-year Mortality in Patients Admitted with Chronic Obstructive Pulmonary Disease. Lung 189, 207–212 (2011). https://doi.org/10.1007/s00408-011-9293-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00408-011-9293-4

Keywords

Navigation